Logo image of TIRX

TIAN RUIXIANG HOLDINGS LTD-A (TIRX) Stock Fundamental Analysis

NASDAQ:TIRX - Nasdaq - KYG8884K1287 - Common Stock - Currency: USD

1.78  -0.02 (-1.11%)

Fundamental Rating

2

Overall TIRX gets a fundamental rating of 2 out of 10. We evaluated TIRX against 144 industry peers in the Insurance industry. TIRX has a great financial health rating, but its profitability evaluates not so good. TIRX is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

TIRX had negative earnings in the past year.
In the past year TIRX had a positive cash flow from operations.
In multiple years TIRX reported negative net income over the last 5 years.
In multiple years TIRX reported negative operating cash flow during the last 5 years.
TIRX Yearly Net Income VS EBIT VS OCF VS FCFTIRX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 2023 0 -2M -4M

1.2 Ratios

Looking at the Return On Assets, with a value of -6.46%, TIRX is doing worse than 94.37% of the companies in the same industry.
With a Return On Equity value of -7.59%, TIRX is not doing good in the industry: 84.51% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -6.46%
ROE -7.59%
ROIC N/A
ROA(3y)-8.37%
ROA(5y)-3.34%
ROE(3y)-8.85%
ROE(5y)-3.38%
ROIC(3y)N/A
ROIC(5y)N/A
TIRX Yearly ROA, ROE, ROICTIRX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 2023 0 5 -5 10 -10 15

1.3 Margins

TIRX does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
TIRX Yearly Profit, Operating, Gross MarginsTIRX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 2023 0 -100 -200 -300

More info and screens

7

2. Health

2.1 Basic Checks

TIRX does not have a ROIC to compare to the WACC, probably because it is not profitable.
TIRX has less shares outstanding than it did 1 year ago.
TIRX has more shares outstanding than it did 5 years ago.
There is no outstanding debt for TIRX. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
TIRX Yearly Shares OutstandingTIRX Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 500K 1M 1.5M
TIRX Yearly Total Debt VS Total AssetsTIRX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 10M 20M 30M 40M

2.2 Solvency

TIRX has an Altman-Z score of 0.55. This is a bad value and indicates that TIRX is not financially healthy and even has some risk of bankruptcy.
TIRX has a Altman-Z score of 0.55. This is in the better half of the industry: TIRX outperforms 73.24% of its industry peers.
TIRX has a debt to FCF ratio of 2.67. This is a good value and a sign of high solvency as TIRX would need 2.67 years to pay back of all of its debts.
TIRX has a Debt to FCF ratio (2.67) which is in line with its industry peers.
TIRX has a Debt/Equity ratio of 0.04. This is a healthy value indicating a solid balance between debt and equity.
Looking at the Debt to Equity ratio, with a value of 0.04, TIRX belongs to the top of the industry, outperforming 87.32% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.04
Debt/FCF 2.67
Altman-Z 0.55
ROIC/WACCN/A
WACC7.54%
TIRX Yearly LT Debt VS Equity VS FCFTIRX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 2023 0 10M 20M 30M

2.3 Liquidity

TIRX has a Current Ratio of 5.06. This indicates that TIRX is financially healthy and has no problem in meeting its short term obligations.
The Current ratio of TIRX (5.06) is better than 95.07% of its industry peers.
A Quick Ratio of 5.06 indicates that TIRX has no problem at all paying its short term obligations.
TIRX's Quick ratio of 5.06 is amongst the best of the industry. TIRX outperforms 95.07% of its industry peers.
Industry RankSector Rank
Current Ratio 5.06
Quick Ratio 5.06
TIRX Yearly Current Assets VS Current LiabilitesTIRX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 10M 20M 30M

More info and screens

0

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 57.09% over the past year.
Looking at the last year, TIRX shows a decrease in Revenue. The Revenue has decreased by -7.96% in the last year.
TIRX shows a very negative growth in Revenue. Measured over the last years, the Revenue has been decreasing by -16.62% yearly.
EPS 1Y (TTM)57.09%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-7.43%
Revenue 1Y (TTM)-7.96%
Revenue growth 3Y-27.38%
Revenue growth 5Y-16.62%
Sales Q2Q%-75.4%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
TIRX Yearly Revenue VS EstimatesTIRX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 1M 2M 3M
TIRX Yearly EPS VS EstimatesTIRX Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

TIRX reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
TIRX Price Earnings VS Forward Price EarningsTIRX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

TIRX's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 8.63
EV/EBITDA N/A
TIRX Per share dataTIRX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for TIRX!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

TIAN RUIXIANG HOLDINGS LTD-A

NASDAQ:TIRX (2/5/2025, 12:29:13 PM)

1.78

-0.02 (-1.11%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupInsurance
GICS IndustryInsurance
Earnings (Last)10-27 2022-10-27/amc
Earnings (Next)N/A N/A
Inst Owners0.11%
Inst Owner ChangeN/A
Ins Owners11.14%
Ins Owner ChangeN/A
Market Cap4.24M
Analysts0
Price TargetN/A
Short Float %17.27%
Short Ratio0.87
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 3.4
P/FCF 8.63
P/OCF 8.63
P/B 0.13
P/tB 0.14
EV/EBITDA N/A
EPS(TTM)-3.87
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.21
FCFY11.59%
OCF(TTM)0.21
OCFY11.59%
SpS0.52
BVpS13.59
TBVpS12.85
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -6.46%
ROE -7.59%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM 39.46%
ROA(3y)-8.37%
ROA(5y)-3.34%
ROE(3y)-8.85%
ROE(5y)-3.38%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.03
Health
Industry RankSector Rank
Debt/Equity 0.04
Debt/FCF 2.67
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 5.06
Quick Ratio 5.06
Altman-Z 0.55
F-Score5
WACC7.54%
ROIC/WACCN/A
Cap/Depr(3y)7.61%
Cap/Depr(5y)119.54%
Cap/Sales(3y)0.1%
Cap/Sales(5y)2.03%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)57.09%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-7.43%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-7.96%
Revenue growth 3Y-27.38%
Revenue growth 5Y-16.62%
Sales Q2Q%-75.4%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y39.01%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y594.18%
FCF growth 3YN/A
FCF growth 5Y-6.14%
OCF growth 1Y600.15%
OCF growth 3YN/A
OCF growth 5Y-6.27%